ProShare Advisors
AMPE

ProShare Advisors’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History

ProShare Advisors’s Portfolio AMPE Stock Details AMPE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-122
Closed -$17K – 2253
2022
Q1 		$17K Sell
122
-20
-14% -$2.92K ﹤0.01% 2185
2021
Q4 		$24K Buy
142
+59
+71% +$22K ﹤0.01% 2326
2021
Q3 		$41K Sell
83
-81
-49% -$37.6K ﹤0.01% 1972
2021
Q2 		$82K Buy
+164
New +$88.1K ﹤0.01% 2314
2019
Q3 		– Sell
-35
Closed -$4K – 1704
2019
Q2 		$4K Hold
35
– – ﹤0.01% 1622
2019
Q1 		$6K Buy
35
+1
+3% +$171 ﹤0.01% 1656
2018
Q4 		$4K Sell
34
-6
-15% -$921 ﹤0.01% 1571
2018
Q3 		$6K Buy
40
+5
+14% +$2.09K ﹤0.01% 1765
2018
Q2 		$23K Buy
+35
New +$26.2K ﹤0.01% 1786
2014
Q4 		– Sell
-54
Closed -$57K – 2173
2014
Q3 		$57K Sell
54
-12
-18% -$20.2K ﹤0.01% 2248
2014
Q2 		$166K Sell
66
-39
-37% -$79.6K ﹤0.01% 2242
2014
Q1 		$200K Buy
+105
New +$248K ﹤0.01% 2518
2013
Q4 		– Sell
-58
Closed -$131K – 1987
2013
Q3 		$131K Buy
58
+2
+4% +$3.87K ﹤0.01% 2339
2013
Q2 		$97K Buy
+56
New +$88.9K ﹤0.01% 2265

Other funds holding AMPE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
AAP
Arax Advisory Partners Denver, Colorado $3.54B AUM 19.14% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ProShare Advisors's AMPE Position: Q2 2022 in Review

ProShare Advisors sold out of Ampio Pharmaceuticals Inc. (AMPE) in Q2 2022, closing a stake of 122 shares — an estimated $17K sold.

ProShare Advisors first reported a position in AMPE in Q2 2013 and held it in 14 quarters. The position peaked at $200K in Q1 2014. 111 funds tracked by Wall St. Rank hold AMPE as of Q2 2022.

  • ProShare Advisors reported no remaining Ampio Pharmaceuticals Inc. position as of Q2 2022 after selling out during the quarter.
  • ProShare Advisors sold 122 Ampio Pharmaceuticals Inc. shares in Q2 2022, an estimated $17K.
  • ProShare Advisors first reported a position in Ampio Pharmaceuticals Inc. in Q2 2013 and held it in 14 quarters.
  • ProShare Advisors's Ampio Pharmaceuticals Inc. position peaked at $200K in Q1 2014.
  • 111 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q2 2022.

Based on ProShare Advisors's 13F filing for Q2 2022, filed 1 Aug 2022.